Trexquant Investment’s Epirus Biopharmaceuticals EPRS Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRS
Trexquant Investment's EPRS Position: Q2 2015 in Review
Trexquant Investment sold out of Epirus Biopharmaceuticals (EPRS) in Q2 2015, closing a stake of 47,846 shares — an estimated $428K sold.
Trexquant Investment first reported a position in EPRS in Q1 2015 and held it in 1 quarter. The position peaked at $428K in Q1 2015. 41 funds tracked by Wall St. Rank hold EPRS as of Q2 2015.
- Trexquant Investment reported no remaining Epirus Biopharmaceuticals position as of Q2 2015 after selling out during the quarter.
- Trexquant Investment sold 47,846 Epirus Biopharmaceuticals shares in Q2 2015, an estimated $428K.
- Trexquant Investment first reported a position in Epirus Biopharmaceuticals in Q1 2015 and held it in 1 quarter.
- Trexquant Investment's Epirus Biopharmaceuticals position peaked at $428K in Q1 2015.
- 41 funds tracked by Wall St. Rank held Epirus Biopharmaceuticals as of Q2 2015.
Based on Trexquant Investment's 13F filing for Q2 2015, filed 12 Aug 2015.